@techcrunch.com 4 years ago
With echoes of Theranos, Truvian Sciences revives the dream of low-cost, accessible blood tests
@techcrunch.com 4 years ago
Lucence raises $20 million Series A for its non-invasive cancer screening technology
@techcrunch.com 9 years ago
Scanadu Raises $35M Series B To Check Your Pee And Scan Your Vitals